1 – 16 of 16
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Deep learning analysis of serial digital breast tomosynthesis images in a prospective cohort of breast cancer patients who received neoadjuvant chemotherapy
(
- Contribution to journal › Article
- 2023
-
Mark
Неоадъювантная химиоиммунотерапия у пациентов раком желудка с микросателлитной нестабильностью
(
- Contribution to journal › Article
-
Mark
Laser ablation-inductively coupled plasma-mass spectrometry analysis reveals differences in chemotherapeutic drug distribution in surgically resected pleural mesothelioma
(
- Contribution to journal › Article
- 2022
-
Mark
The association between body mass index and pathological complete response in neoadjuvant-treated breast cancer patients
(
- Contribution to journal › Article
-
Mark
High infiltration of CD68+/CD163- macrophages is an adverse prognostic factor after neoadjuvant chemotherapy in esophageal and gastric adenocarcinoma
(
- Contribution to journal › Article
- 2021
-
Mark
Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG study
(
- Contribution to journal › Article
-
Mark
Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients
(
- Contribution to journal › Article
-
Mark
Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer
(
- Contribution to journal › Article
-
Mark
Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer
(
- Contribution to journal › Article
-
Mark
T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy : relationship with histopathological response and survival
(
- Contribution to journal › Article
- 2020
-
Mark
No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy : a nation-wide register-based study
(
- Contribution to journal › Article
-
Mark
Mammographic density. A marker of treatment outcome in breast cancer?
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2019
-
Mark
Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer : a comparative study of transurethral resection and cystectomy specimens
(
- Contribution to journal › Article
- 2018
-
Mark
Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
(
- Contribution to journal › Article
- 2017
-
Mark
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
(
- Contribution to journal › Article
- 2014
-
Mark
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial
(
- Contribution to journal › Article